Designing a biomedical net for heart valve implant

维萨里心血管是一家医疗器械公司。该公司正在设计和开发一种无需手术即可修复二尖瓣反流的外科植入物。**目前的黄金标准治疗是开胸手术。由于手术的风险，大量患者无法接受手术，也无法得到治疗。Vesalius Cardiovascular的目标是用一种新的方法来取代开胸手术，即通过静脉植入并将其部署到心脏左侧。病人不再需要开胸手术了。**Vesalius Cardiovascular处于工程阶段，需要大量的机械设计和工程来构建植入物并将物理定律应用于临床环境。**公司需要大量的机械工程研发来定义网的特性，网是植入物的主要组成部分。这个NSERC项目涉及网络。该研究项目将涵盖设计和测试网络，并将包括材料研究、数据和尺寸、与移动传单的相互作用、与血流的相互作用以及与其他材料的整合。

Vesalius Cardiovascular is a medical device company. The company is designing and developing a surgical**implant able to repair mitral regurgitation, without operation.**The gold standard treatment is currently open-heart surgery. Due to risks associated with the surgery, a large**number of patients cannot undergo an operation and subsequently cannot be treated. Vesalius Cardiovascular**goal is to replace the open-heart surgery with a procedure, i.e. an implant delivered through the vein and**deployed to the left side of the heart. The patient will not require open-heart surgery anymore.**Vesalius Cardiovascular is at the engineering phase, requiring heavy mechanical design and engineering to**build the implant and apply physics law to a clinical environment.**The company requires extensive mechanical engineering R&D to define the characteristics of the net, a major**component of the implant. This NSERC project concerns the net. The research project will cover designing and**testing the net and will include material studies, data and dimensions, interaction with moving leaflets,**interaction with blood flow and integration with other materials.